Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 11, 2016 1:58 AM ET

Biotechnology

Company Overview of Cytokinetics, Incorporated

Executive Profile

Paul A. Wender Ph.D.

Member of Scientific Advisory Board, Cytokinetics, Incorporated
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 3 different industries.

See Board Relationships
----

Background

Prof. Paul A. Wender, Ph.D. co-founded Progen Pharmaceuticals, Inc. in 1998 and served as its Chief Scientific Advisor. Prof. Wender serves as a Consultant to various pharmaceutical companies. Prof. Wender is a Co-Founder of Quantitative Chemical Biology Program at Stanford University. He has joint appointment in Chemistry and in the Medical School at Stanford University. He was Bergstrom Professor of Chemistry and Professor of Molecular Pharmacology at Stanford University. ...

Corporate Headquarters

280 East Grand Avenue
South San Francisco, California 94080

United States

Phone: 650-624-3000
Fax: 650-624-3010

Board Members Memberships

There is no Board Members Memberships data available.

Education

PhD
Yale University
BS
Wilkes University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Paolo Pucci Chief Executive Officer and Director
ArQule Inc.
$489.3K
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma Inc.
$558.3K
James A. Bianco M.D.Chief Executive Officer, President, Principal Founder, Executive Director and Member of Executive Committee
CTI BioPharma Corp.
$1.3M
Ali Fattaey Ph.D.Chief Executive Officer, President and Director
Curis, Inc.
$464.2K
Adelene Q. Perkins Chairman of The Board, Chief Executive Officer and President
Infinity Pharmaceuticals, Inc.
$568.5K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Cytokinetics, Incorporated, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.